DWTX Stock Summary and Trading Ideas (Dogwood Therapeutics | NASDAQ:DWTX)

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Dogwood Therapeutics trades on the NASDAQ stock market under the symbol DWTX.

As of December 23, 2025, DWTX stock price declined to $3.80 with 191,693 million shares trading.

DWTX has a beta of 1.33, meaning it tends to be more sensitive to market movements. DWTX has a correlation of 0.01 to the broad based SPY ETF.

DWTX has a market cap of $112.97 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that DWTX belongs to (by Net Assets): VXF.

DWTX has outperformed the market in the last year with a return of +62.4%, while the SPY ETF gained +17.5%. However, in the most recent history, DWTX shares have underperformed the stock market with its stock returning -26.6% in the last 3 month period and -36.6% for the last 2 week period, while SPY has returned +3.4% and +0.9%, respectively.

DWTX support price is $4.50 and resistance is $5.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DWTX shares will trade within this expected range on the day.